Clinical trial
Anticoagulation in Blunt Cerebrovascular Injuries
NCT00494156 · C. Clay Cothren, MD, Other · Withdrawn
Key facts
| NCT number | NCT00494156 |
|---|---|
| Title | Anticoagulation in Blunt Cerebrovascular Injuries |
| Official title | Anticoagulation in the Management of Grade I-III Blunt Cerebrovascular Injuries |
| Lead sponsor | C. Clay Cothren, MD, Other |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Carotid Artery Injury, Vertebral Artery Injury |
| Intervention type | Drug |
| Interventions | heparin, aspirin and clopidogrel |
| Enrollment | 0 |
| Start date | Jul 1, 2003 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jun 29, 2007 |
| Last update posted | Oct 21, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: